Cosmetics Regulation:
Information on Voluntary Actions Agreed to by FDA and the Industry
HRD-90-58: Published: Mar 13, 1990. Publicly Released: Apr 10, 1990.
Additional Materials:
- Full Report:
Contact:
Pursuant to a congressional request, GAO reviewed the Food and Drug Administration's (FDA) and a cosmetics industry association's actions to increase: (1) voluntary registration of cosmetics establishments; and (2) safety data and injury reporting by cosmetics manufacturers, packers, or distributors.
GAO found that: (1) FDA and the association took measures to encourage greater industry participation in the voluntary registration program, which included reducing paperwork and emphasizing the importance of registration at industry meetings, but could not accurately assess how many companies were avoiding participation or whether industry efforts resulted in increased reporting of safety testing; (2) the number of companies registered increased from 94 to 778 between 1988 and 1989; (3) many manufacturers lacked adequate data on safety tests and refused to disclose the results of the tests; (4) about 3 percent of an estimated 4,000 to 5,000 cosmetic distributors filed injury reports; and (5) FDA had no plans to conduct safety reviews or priority ranking of toxic chemicals.
Jan 14, 2021
-
Medicaid:
Data Completeness and Accuracy Have Improved, Though Not All Standards Have Been MetGAO-21-196: Published: Jan 14, 2021. Publicly Released: Jan 14, 2021.
Jan 4, 2021
-
Medicare Severe Wound Care:
Spending Declines May Reflect Site of Care Changes; Limited Information Is Available on QualityGAO-21-92: Published: Jan 4, 2021. Publicly Released: Jan 4, 2021.
Dec 22, 2020
-
Defense Health Care:
Efforts to Ensure Beneficiaries Access Specialty Care and Receive Timely and Effective CareGAO-21-143: Published: Dec 22, 2020. Publicly Released: Dec 22, 2020.
Dec 16, 2020
-
Medicaid Long-Term Services and Supports:
Access and Quality Problems in Managed Care Demand Improved OversightGAO-21-49: Published: Nov 16, 2020. Publicly Released: Dec 16, 2020.
Dec 14, 2020
-
Drug Pricing Program:
HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B RequirementsGAO-21-107: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020. -
Substance Use Disorder:
Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant ProgramGAO-21-58: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020.
Dec 10, 2020
-
Indian Health Service:
Actions Needed to Improve Oversight of Provider Misconduct and Substandard PerformanceGAO-21-97: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020. -
Clinical Labs:
Studies Suggest Biopsy Specimen Misidentification and Contamination Errors Are InfrequentGAO-21-59: Published: Nov 10, 2020. Publicly Released: Dec 10, 2020.
Dec 7, 2020
-
Medicaid:
CMS Needs More Information on States' Financing and Payment Arrangements to Improve OversightGAO-21-98: Published: Dec 7, 2020. Publicly Released: Dec 7, 2020.
Dec 1, 2020
-
Military Health Care:
Defense Health Agency Processes for Responding to Provider Quality and Safety ConcernsGAO-21-160R: Published: Dec 1, 2020. Publicly Released: Dec 1, 2020.
Looking for more? Browse all our products here